Cell And Gene Therapy Contract Development And Manufacturing Organization Market Share

Statistics for the 2023 & 2024 Cell And Gene Therapy Contract Development And Manufacturing Organization market share, created by Mordor Intelligence™ Industry Reports. Cell And Gene Therapy Contract Development And Manufacturing Organization share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Cell And Gene Therapy Contract Development And Manufacturing Organization Market Market Share

Market Share of Cell And Gene Therapy Contract Development And Manufacturing Organization Industry

The market for cell and gene therapy contract development and manufacturing organizations is moderately competitive, with the presence of both small and large players who are involved in strategic activities such as the expansion of services, partnerships, collaborations, as well as mergers, and acquisitions. Catalent, Inc., Lonza, Wuxi Biologics, and Recipharm Ab are among the notable key players in this market.

Cell And Gene Therapy Contract Development And Manufacturing Organization Market Leaders

  1. Catalent Inc

  2. Lonza Group

  3. Recipharm AB

  4. Charles River Laboratories International Inc

  5. Wuxi Advanced Therapies

*Disclaimer: Major Players sorted in no particular order

Cell And Gene Therapy Contract Development And Manufacturing Organization Market Concentration

Cell And Gene Therapy Contract Development And Manufacturing Organization Market Report Snapshots

Cell and Gene Therapy Contract Development and Manufacturing Organization Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)